Back
Daxor Vs. Perspective Therapeutics Industry Stock Comparison
Sell
29
DXR
Daxor
Last Price:
9.45
Seasonality Move:
13.17%
Sell
30
CATX
Perspective Therapeutics
Last Price:
4.13
Seasonality Move:
34.33%
Sell
29
Daxor (DXR)
is a Sell
Is Daxor a Buy, Sell or Hold?
- The current Daxor [DXR] share price is $9.45. The Score for DXR is 29, which is 42% below its historic median score of 50, and infers higher risk than normal.
- DXR is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
30
Perspective Therapeutics (CATX)
is a Sell
Is Perspective Therapeutics a Buy, Sell or Hold?
- The current Perspective Therapeutics [CATX] share price is $4.12. The Score for CATX is 30, which is 40% below its historic median score of 50, and infers higher risk than normal.
- CATX is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
CATX Stock Price Chart
What is Perspective Therapeutics's stock price today?
-
The Perspective Therapeutics share price today is $4.12
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and CATX is experiencing selling pressure, which indicates risk of future bearish movement.
DXR Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.12 | Buy |
| Relative Strength Index (14 RSI): | 54.72 | Buy |
| Chaikin Money Flow: | 4530 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (8.75 - 9.43) | Buy |
| Bollinger Bands (100): | (8.61 - 9.35) | Buy |
CATX Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -2.25 | Sell |
| Relative Strength Index (14 RSI): | 22.48 | Sell |
| Chaikin Money Flow: | -2235934 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (5.92 - 12.44) | Sell |
| Bollinger Bands (100): | (9.65 - 14.99) | Sell |
DXR Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 9.25 | Buy |
| 20-day SMA: | 9.16 | Buy |
| 50-day SMA: | 9.04 | Buy |
| 200-day SMA: | 8.98 | Buy |
| 8-day EMA: | 9.34 | Buy |
| 20-day EMA: | 9.19 | Buy |
| 50-day EMA: | 9.08 | Buy |
| 200-day EMA: | 9.05 | Buy |
CATX Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 4.82 | Sell |
| 20-day SMA: | 8.54 | Sell |
| 50-day SMA: | 10.99 | Sell |
| 200-day SMA: | 12.65 | Sell |
| 8-day EMA: | 5.11 | Sell |
| 20-day EMA: | 7.53 | Sell |
| 50-day EMA: | 10.11 | Sell |
| 200-day EMA: | 11.14 | Sell |
Daxor Earnings Growth & DXR Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Perspective Therapeutics Earnings Growth & CATX Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.16 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.79 per share, and a decrease next year of $0.49 per share.
Daxor Technical Analysis
| Nov 14 | Nov 15 | Nov 18 | Nov 19 | Nov 20 | Nov 21 | Nov 22 | Nov 25 | Nov 26 | Nov 27 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov | ||||||||||
| 14 | 15 | 18 | 19 | 20 | 21 | 22 | 25 | 26 | 27 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Perspective Therapeutics Technical Analysis
| Nov 14 | Nov 15 | Nov 18 | Nov 19 | Nov 20 | Nov 21 | Nov 22 | Nov 25 | Nov 26 | Nov 27 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov | ||||||||||
| 14 | 15 | 18 | 19 | 20 | 21 | 22 | 25 | 26 | 27 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||